Boothbay Fund Management, LLC Clene Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.1 - $4.12 $73,298 - $143,804	-34,904 Reduced 70.84%	14,370 $36,000
Q3 2021 Nov 15, 2021	BUY	$6.83 - $13.58 $245,866 - $488,852	35,998 Added 271.15%	49,274 $337,000
Q2 2021 Aug 16, 2021	SELL	$6.98 - $13.33 $25,525 - $48,747	-3,657 Reduced 21.6%	13,276 $149,000
Q1 2021 May 17, 2021	BUY	$6.39 - $16.3 $39,004 - $99,495	6,104 Added 56.37%	16,933 $216,000
Q4 2020 Feb 12, 2021	BUY	$10.75 - $12.97 $116,411 - $140,452	10,829 New	10,829 $98,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.